Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 44

1.

Interleukin-13 in Asthma and Other Eosinophilic Disorders.

Doran E, Cai F, Holweg CTJ, Wong K, Brumm J, Arron JR.

Front Med (Lausanne). 2017 Sep 19;4:139. doi: 10.3389/fmed.2017.00139. eCollection 2017.

2.

Translational Animal Models of Atopic Dermatitis for Preclinical Studies

.

Martel BC, Lovato P, Bäumer W, Olivry T.

Yale J Biol Med. 2017 Sep 25;90(3):389-402. eCollection 2017 Sep. Review.

3.

Poly-ADP ribose polymerase-14 limits severity of allergic skin disease.

Krishnamurthy P, Da-Silva-Arnold S, Turner MJ, Travers JB, Kaplan MH.

Immunology. 2017 Nov;152(3):451-461. doi: 10.1111/imm.12782. Epub 2017 Jul 27.

PMID:
28653395
4.

Activated Natural Killer Cells Mediate the Suppressive Effect of Interleukin-4 on Tumor Development via STAT6 Activation in an Atopic Condition Melanoma Model.

Son DJ, Jung YY, Park MH, Lee HL, Song MJ, Yoo HS, Hwang DY, Han SB, Hong JT.

Neoplasia. 2017 Jul;19(7):537-548. doi: 10.1016/j.neo.2017.02.014. Epub 2017 Jun 3.

5.

Prostaglandin E2 stimulates adaptive IL-22 production and promotes allergic contact dermatitis.

Robb CT, McSorley HJ, Lee J, Aoki T, Yu C, Crittenden S, Astier A, Felton JM, Parkinson N, Ayele A, Breyer RM, Anderton SM, Narumiya S, Rossi AG, Howie SE, Guttman-Yassky E, Weller RB, Yao C.

J Allergy Clin Immunol. 2018 Jan;141(1):152-162. doi: 10.1016/j.jaci.2017.04.045. Epub 2017 Jun 3.

PMID:
28583370
6.

The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies.

Brunner PM, Guttman-Yassky E, Leung DY.

J Allergy Clin Immunol. 2017 Apr;139(4S):S65-S76. doi: 10.1016/j.jaci.2017.01.011. Review.

PMID:
28390479
7.

Stratum Corneum Tape Stripping: Monitoring of Inflammatory Mediators in Atopic Dermatitis Patients Using Topical Therapy.

Koppes SA, Brans R, Ljubojevic Hadzavdic S, Frings-Dresen MH, Rustemeyer T, Kezic S.

Int Arch Allergy Immunol. 2016;170(3):187-93. doi: 10.1159/000448400. Epub 2016 Sep 2.

8.

STAT6 and PARP Family Members in the Development of T Cell-dependent Allergic Inflammation.

Krishnamurthy P, Kaplan MH.

Immune Netw. 2016 Aug;16(4):201-10. doi: 10.4110/in.2016.16.4.201. Epub 2016 Aug 23. Review.

9.

IL-4 impairs wound healing potential in the skin by repressing fibronectin expression.

Serezani APM, Bozdogan G, Sehra S, Walsh D, Krishnamurthy P, Sierra Potchanant EA, Nalepa G, Goenka S, Turner MJ, Spandau DF, Kaplan MH.

J Allergy Clin Immunol. 2017 Jan;139(1):142-151.e5. doi: 10.1016/j.jaci.2016.07.012. Epub 2016 Aug 20.

10.

Increased Th2 activity and diminished skin barrier function cooperate in allergic skin inflammation.

Sehra S, Krishnamurthy P, Koh B, Zhou HM, Seymour L, Akhtar N, Travers JB, Turner MJ, Kaplan MH.

Eur J Immunol. 2016 Nov;46(11):2609-2613. doi: 10.1002/eji.201646421. Epub 2016 Aug 29.

11.

Molecular Mechanisms of Cutaneous Inflammatory Disorder: Atopic Dermatitis.

Kim JE, Kim JS, Cho DH, Park HJ.

Int J Mol Sci. 2016 Jul 30;17(8). pii: E1234. doi: 10.3390/ijms17081234. Review.

12.

Environmental risk factors and their role in the management of atopic dermatitis.

Kantor R, Silverberg JI.

Expert Rev Clin Immunol. 2017 Jan;13(1):15-26. Epub 2016 Jul 28. Review.

13.

Mast Cells Regulate Epidermal Barrier Function and the Development of Allergic Skin Inflammation.

Sehra S, Serezani APM, Ocaña JA, Travers JB, Kaplan MH.

J Invest Dermatol. 2016 Jul;136(7):1429-1437. doi: 10.1016/j.jid.2016.03.019. Epub 2016 Mar 25.

14.

1-palmitoyl-2-linoleoyl-3-acetyl-rac-glycerol (EC-18) Modulates Th2 Immunity through Attenuation of IL-4 Expression.

Yoon SY, Kang HB, Ko YE, Shin SH, Kim YJ, Sohn KY, Han YH, Chong S, Kim JW.

Immune Netw. 2015 Apr;15(2):100-9. doi: 10.4110/in.2015.15.2.100. Epub 2015 Apr 23.

15.

Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches.

Leung DY, Guttman-Yassky E.

J Allergy Clin Immunol. 2014 Oct;134(4):769-79. doi: 10.1016/j.jaci.2014.08.008. Review.

16.

SERPINB3/B4 contributes to early inflammation and barrier dysfunction in an experimental murine model of atopic dermatitis.

Sivaprasad U, Kinker KG, Ericksen MB, Lindsey M, Gibson AM, Bass SA, Hershey NS, Deng J, Medvedovic M, Khurana Hershey GK.

J Invest Dermatol. 2015 Jan;135(1):160-169. doi: 10.1038/jid.2014.353. Epub 2014 Aug 11.

18.

STAT6-mediated keratitis and blepharitis: a novel murine model of ocular atopic dermatitis.

Turner MJ, DaSilva-Arnold S, Luo N, Hu X, West CC, Sun L, Hall C, Bradish J, Kaplan MH, Travers JB, Sun Y.

Invest Ophthalmol Vis Sci. 2014 May 20;55(6):3803-8. doi: 10.1167/iovs.13-13685.

19.

Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology.

Khattri S, Shemer A, Rozenblit M, Dhingra N, Czarnowicki T, Finney R, Gilleaudeau P, Sullivan-Whalen M, Zheng X, Xu H, Cardinale I, de Guzman Strong C, Gonzalez J, Suárez-Fariñas M, Krueger JG, Guttman-Yassky E.

J Allergy Clin Immunol. 2014 Jun;133(6):1626-34. doi: 10.1016/j.jaci.2014.03.003. Epub 2014 Apr 29. Erratum in: J Allergy Clin Immunol. 2014 Sep;134(3):764.

20.

Delineating the role of histamine-1- and -4-receptors in a mouse model of Th2-dependent antigen-specific skin inflammation.

Mahapatra S, Albrecht M, Behrens B, Jirmo A, Behrens G, Hartwig C, Neumann D, Raap U, Bähre H, Herrick C, Dittrich AM.

PLoS One. 2014 Feb 4;9(2):e87296. doi: 10.1371/journal.pone.0087296. eCollection 2014.

Supplemental Content

Support Center